I see low trade volume as a good sign as we await the trial...

I see low trade volume as a good sign as we await the trial results. As soon as we hear last patient enrolled she's gonna move up very quickly. To say it is a dead stock when the company is doing its first human trials on potentially world changing imaging just shows how little you understand about what is happening and the massive disruption to the imaging world this will make. We'll see where this is when results come out but I am pretty sure your comments will sound really stupid.